Please provide your email address to receive an email ... Disclosures: Lee reports consulting for Alexion, Amgen/Horizon, AstraZeneca, Bristol Myers Squibb, Catalyst, Dompe, Etyreal, Stoke ...

San Diego—May 19, 2025–Rady Children’s Institute for Genomic Medicine (RCIGM®) today announced that Alexion, AstraZeneca Rare Disease has signed on as the first Platinum member of the Begin ...

Alexion has routinely featured among lists of top biopharma takeover prospects in the last couple of years, and that was a good call – AstraZeneca has just swooped in with $39 billion cash-and ...

AstraZeneca’s rare disease firm Alexion is set to expand its genomic medicine portfolio with the acquisition of gene editing specialist LogicBio Therapeutics, in a deal worth approximately $68 ...

AstraZeneca Plc’s experimental breast cancer pill delayed disease progression by over six months, according to data from a ...

The Federal Court has granted Alexion a declaration of infringement and an injunction preventing Amgen from manufacturing, ...

AstraZeneca CEO Pascal Soriot views the company's stock price — up just 10% year-to-date — as a marker of how he is doing. He ...

Data presented at ASCO show that swapping in the oral drug camizestrant for an older therapy helped sustain the benefit of ...

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...

Treating breast cancer patients with AstraZeneca’s experimental pill camizestrant at the first sign of resistance to standard treatments cut the risk of disease progression or death by half, a finding ...

The one thing Inama has left up on her walls, for now: a sign that says “Everyone is welcome here,” above hands with different skin tones. The sign, administrators at the West Ada School ...

Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, ...